01330nas a2200493   4500000000100000008004100001260001600042653001900058653001500077653001000092653000900102653001300111653002200124653002900146653001500175653002900190653001100219653001900230653003000249653001100279653003000290653002300320653001700343653001200360653001600372653002000388653002200408653001900430653001400449653001800463653002800481653003000509653003100539653002200570653002100592100001500613700001500628700001200643700001500655245013200670300001200802490000800814022001400822       1974                            d  c1974 Feb 0110aAdenocarcinoma10aAdolescent10aAdult10aAged10aAntigens10aCarcinoma in Situ10aCarcinoma, Squamous Cell10aCroton Oil10aFallopian Tube Neoplasms10aFemale10aFluorobenzenes10aGenital Neoplasms, Female10aHumans10aHypersensitivity, Delayed10aImmunity, Cellular10aInflammation10aleprosy10aMiddle Aged10aNitro Compounds10aOvarian Neoplasms10aPilot Projects10aPregnancy10aSkin Diseases10aTrophoblastic Neoplasms10aUterine Cervical Diseases10aUterine Cervical Neoplasms10aUterine Neoplasms10aVulvar Neoplasms1 aNalick R H1 aDiSaia P J1 aRea T H1 aMorrow M H00aImmunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations.  a393-4050 v118  a0002-9378